Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000127

EVP, Chief Technical Ops. Off. sold 2,650 shares at $475.34 ($1,259,651)

  • EVP, Chief Technical Ops. Off. gave up 2,482 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-26 Shares withheld for taxes : show line 1 in the form 10b5-1 −2,482 $479.61 $1,190,392 22,002 D
2025-02-27 Sale : show line 2 in the form 10b5-1 −2,650 $475.34 $1,259,651 19,352 D
Open-market sales · 2,650 sh · avg $475.34 · $1,259,651
Loading xslF345X05/wk-form4_1740778570.xml…